Shield Therapeutics plc
Shield Therapeutics plc is a pharmaceutical company focused on developing medicines for individuals suffering from iron deficiency. Their lead product, ACCRUFeR®, is an oral therapy approved for use in multiple regions, addressing needs in iron deficiency treatment.
- Specialty pharmaceuticals addressing unmet medical needs
- ACCRUFeR® (ferric maltol) - oral therapy for iron deficiency
Locations
Company Details
Shield Therapeutics plc is operated by Shield Therapeutics Plc and is a Active company incorporated on 3 September 2015 with the registered office located in Gateshead, Tyne and Wear. Shield Therapeutics Plc was registered 10 years ago.
Status
Active
Size
Medium
Directors
8
Age
10 years old
Employees
77
Turnover
£25.7M
Total Assets
£45.91M
Cash in Bank
£5.61M
Total Liabilities
-£46.96M
Teams
8
3
3
3
2
Vice President, Quality, Clinical And Regulatory Affairs • Joined Jan 2012
Human Resources • Joined Sep 2016
Supply Chain Lead • Joined Nov 2023
Finance Manager • Joined Jul 2024
Head Of Pharmacovigilance And Medical Information • Joined Feb 2016
Administrative Assistant • Joined Aug 2019
Finance Assistant
Group Financial Controller • Joined Oct 2019
Human Resources • Joined Sep 2016
Administrative Assistant • Joined Aug 2019
Finance Assistant
Human Resources • Joined Sep 2016
Head Of Pharmacovigilance And Medical Information • Joined Feb 2016
Group Financial Controller • Joined Oct 2019
Finance Manager • Joined Jul 2024
Finance Assistant
Group Financial Controller • Joined Oct 2019
Vice President, Quality, Clinical And Regulatory Affairs • Joined Jan 2012
Supply Chain Lead • Joined Nov 2023